ZBIO Zenas BioPharma, Inc.: institutional ownership and insider trading
152 funds reported holding $1.61B of Zenas BioPharma, Inc. in their latest 13F filings; in Q2 2026 funds net bought $88.2M, with 26 new positions and 21 funds selling out; over the last 12 months insiders bought $11.4M and sold $0 on the open market.
ZBIO revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.00M, net income −$111M, EPS -1.77
- Quarter ended Mar 31, 2026: revenue n/a, net income −$81.0M, EPS -1.46
- Quarter ended Dec 31, 2025: revenue $0, net income −$240M, EPS -5.17
- Quarter ended Sep 30, 2025: revenue $0, net income −$51.5M, EPS -1.22
Famous investors holding ZBIO
- Two Sigma (Two Sigma Investments): $20.7M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $16.8M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $5.75M, 0.0% of the portfolio
Largest institutional holders of ZBIO
- FMR LLC — $241M
- SR ONE CAPITAL MANAGEMENT, LP — $128M
- NEA Management Company, LLC — $102M
- Enavate Sciences GP, LLC — $99.5M
- FEDERATED HERMES, INC. (FHI) — $79.1M
- BlackRock, Inc. (BLK) — $68.2M
- Capital International Investors — $63.5M
- Polar Capital Holdings Plc — $61.2M
- Royalty Pharma Sub-Manager, LLC — $60.6M
- Fairmount Funds Management LLC — $59.9M
Recent ZBIO insider trades
- May 18, 2026: Moulder Leon O Jr bought 60,000 shares ($1.01M)
- Apr 29, 2026: Moulder Leon O Jr bought 60,000 shares ($1.07M)
- Mar 31, 2026: Lu Hongbo bought 3,768 shares ($70.2K)
- Mar 31, 2026: Harwin Peter Evan bought 150,000 shares ($3.00M)
5%+ owners
- InnoCare Pharma Inc.: 10.4% (Schedule 13G/A, filed Sep 8, 2026)
- Wellington Management Group LLP: 10.1% (Schedule 13G, filed Sep 8, 2026)
- SR One Capital Management, LLC: 7.7% (Schedule 13D/A, filed Aug 17, 2026)
- MOULDER LEON O JR: 5.1% (Schedule 13D, filed May 5, 2026)
Who owns the most ZBIO stock?
The largest institutional holders of Zenas BioPharma, Inc. in the latest 13F filings are FMR LLC ($241M), SR ONE CAPITAL MANAGEMENT, LP ($128M), NEA Management Company, LLC ($102M).
Are insiders buying or selling ZBIO?
Over the last 12 months insiders bought $11.4M and sold $0 of Zenas BioPharma, Inc. stock on the open market (SEC Form 4).
Which famous investors own ZBIO?
Two Sigma, Izzy Englander, Ken Griffin.
What was ZBIO's revenue last quarter?
Zenas BioPharma, Inc. reported revenue of $1.00M for the quarter ended June 30, 2026, with net income of −$111M.
Which ETFs hold ZBIO?
18 ETFs and mutual funds hold it among their top 100 positions, including VGHAX, KAUAX, FKAIX, FHCLX.